There’s been quite a lot of commotion around NanoTech Entertainment, Inc. (OTCMKTS:NTEK) recently and it’s definitely having an effect on the stock. Friday’s session ended with a further 33% gained which means that the...
The tough year for Amarantus Biosciences Inc (OTC:AMBS) is continuing. It all started when their stock prices plummeted in the first half of January. They fell from $0.18 per share to right around $0.070....
A long-embattled ticker, Amarantus Biosciences, Inc. (OTC:AMBS) , is charting a small rising trend in the past days, adding nearly a third to its price on healthy volumes, nearing 8 cents. The success of...
Dogs are a man’s best friend, and lately pet healthcare has employed more and more advanced technologies to give that friend the best chance possible. Now a biotechnology company is riding this trend, offering...
We have been waiting for a couple of weeks for Amarantus Bioscience, Inc. (OTC:AMBS) to choose a direction, and while the ticker has been stagnant for a while, the company is pointing to developments...
Amarantus Biosciences, Inc. (OTC:AMBS) is not giving up on its positions, even though the active promotions for the ticker stopped in mid-December. The biotechnology company added 16% to its price on Friday’s trading and...
Most biotechnological companies run a race against time, with a long development period and uncertainty until the therapies or products achieve lasting marketing success. This is the case of Generex Biotechnology Corp. (OTC:GNBT), a...
After crashing over 27% on Wednesday, in yesterday’s session Amarantus Bioscience, Inc. (OTC:AMBS) caved in another 28% down to a close of $0.069 per share. Just a week ago the stock was trading at...
Yesterday’s trading session saw Amarantus Bioscience, Inc. (OTC:AMBS) drop over 27% and have nearly 4 cents sliced off its share price. What is particularly unsettling about the slip is that it happens immediately after...
After exploding on the market in three consecutive sessions, yesterday Amarantus Bioscience, Inc. (OTC:AMBS) cooled down and closed nearly 13% down. The stock is still latched to the top three most heavily traded OTC...